Alzheimer’s Association® and American College of Radiology® (ACR®) Announce Recruiting for the “New IDEAS Study” with Special Focus on African American and Latino Participants
The need for better tools to provide earlier and more accurate diagnosis of Alzheimer’s and other dementia is critical. The urgency is even higher with potential new treatments on the horizon, including the need for clinicians to demonstrate presence or absence of brain amyloid to make treatment decisions.
Building on the momentum of the IDEAS Study , the Alzheimer’s Association and the American College of Radiology, with manufacturing partners Eli Lilly and Co., GE Healthcare, and Life Molecular Imaging, have launched recruiting for the New IDEAS: Imaging Dementia—Evidence for Amyloid Scanning study.